SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NVS: Novartis AG -- Ignore unavailable to you. Want to Upgrade?

To: Dave who wrote (58)6/7/2001 7:09:34 PM
From: Starlight  Respond to of 116
 
Dave - I agree with your assessment, and all we can hope for is that some of these cancer drugs will find more widespread usage and more coverage by insurance companies.

Betty



To: Dave who wrote (58)6/8/2001 10:07:57 AM
From: STEVE  Read Replies (3) | Respond to of 116
 
Dave, you make a very good point that their potential revenue is limited with this drug but hasn't there pipeline improved like five-fold in the last couple of years
with lots of other promising drugs on the horizon.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News